About all

Skelaxin medicine: Drug Database | Medication Decision Support


Skelaxin Oral: Uses, Side Effects, Interactions, Pictures, Warnings & Dosing

See also How to Use section.

Drug interactions may change how your medications work or increase your risk for serious side effects. This document does not contain all possible drug interactions. Keep a list of all the products you use (including prescription/nonprescription drugs and herbal products) and share it with your doctor and pharmacist. Do not start, stop, or change the dosage of any medicines without your doctor’s approval.

Some products that may interact with this drug include: diet pills/appetite suppressants (such as diethylpropion), drugs for attention deficit disorder (such as atomoxetine, methylphenidate), apraclonidine, bupropion, buspirone, carbamazepine, cyclobenzaprine, deutetrabenazine, a certain combination product (dextromethorphan/quinidine), levodopa, maprotiline, methyldopa, metoclopramide, certain opioid pain relievers (such as fentanyl, meperidine, methadone, tapentadol), certain drugs for Parkinson’s disease (such as entacapone, tolcapone), certain supplements (such as tryptophan, tyramine), tetrabenazine, tricyclic antidepressants (such as amitriptyline, doxepin), valbenazine.

The risk of serotonin syndrome/toxicity increases if you are also taking other drugs that increase serotonin. Examples include street drugs such as MDMA/”ecstasy,” St. John’s wort, certain antidepressants (including mirtazapine, SSRIs such as fluoxetine/paroxetine, SNRIs such as duloxetine/venlafaxine), tramadol, certain “triptans” used to treat migraine headaches (such as rizatriptan, sumatriptan, zolmitriptan), among others. The risk of serotonin syndrome/toxicity may be more likely when you start or increase the dose of these drugs.

Some products can interact with metaxalone if you take them together, or even if you take them weeks before or after taking metaxalone. Tell your doctor or pharmacist if you take anything in the list of products that may interact with this drug, or any of the products that increase serotonin, within 2 weeks before or after taking metaxalone. Also tell them if you have taken fluoxetine within 5 weeks before starting metaxalone. Ask your doctor how much time to wait between starting or stopping any of these drugs and starting metaxalone.

Taking other MAO inhibitors with this medication may cause a serious (possibly fatal) drug interaction. Do not take any other MAO inhibitors (isocarboxazid, linezolid, methylene blue, moclobemide, phenelzine, procarbazine, rasagiline, safinamide, selegiline, tranylcypromine) during treatment with this medication. Most MAO inhibitors should also not be taken for two weeks before and after treatment with this medication. Ask your doctor when to start or stop taking this medication.

Before using metaxalone, report the use of drugs that may increase the risk of extremely high blood pressure (hypertensive crisis) when combined with metaxalone, including herbal products (such as ephedra/ma huang), nasal decongestants (such as phenylephrine, pseudoephedrine), and stimulants (such as amphetamines, ephedrine, epinephrine, phenylalanine). Metaxalone should not be used with any of these medications. Talk to your doctor or pharmacist for more details.

Tell your doctor or pharmacist if you are taking other products that cause drowsiness such as opioid pain or cough relievers (such as codeine, hydrocodone), alcohol, marijuana (cannabis), drugs for sleep or anxiety (such as alprazolam, lorazepam, zolpidem), other muscle relaxants (such as carisoprodol, cyclobenzaprine), or antihistamines (such as cetirizine, diphenhydramine).

Check the labels on all your medicines (such as allergy or cough-and-cold products) because they may contain ingredients that cause drowsiness. Ask your pharmacist about using those products safely.

This medication may interfere with certain lab tests (such as certain urine glucose tests), possibly causing false test results. Make sure lab personnel and all your doctors know you use this drug.

Does Skelaxin interact with other drugs you are taking?

Enter your medication into the WebMD interaction checker

Metaxalone: MedlinePlus Drug Information

pronounced as (me tax’ a lone)

To use the sharing features on this page, please enable JavaScript.

  • Why is this medication prescribed?
  • How should this medicine be used?
  • Other uses for this medicine
  • What special precautions should I follow?
  • What should I do if I forget a dose?
  • What side effects can this medication cause?
  • What should I know about storage and disposal of this medication?
  • In case of emergency/overdose
  • What other information should I know?
  • Brand names

Metaxalone, a muscle relaxant, is used with rest, physical therapy, and other measures to relax muscles and relieve pain and discomfort caused by strains, sprains, and other muscle injuries.

Metaxalone comes as a tablet to take by mouth. It usually is taken three or four times a day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take metaxalone exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.

This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.

Before taking metaxalone,

  • tell your doctor and pharmacist if you are allergic to metaxalone, any other medications, or any of the ingredients in metaxalone tablets. Ask your pharmacist for a list of the ingredients.
  • tell your doctor and pharmacist what prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take while taking metaxolone. Your doctor may need to change the doses of your medications or monitor you carefully for side effects.
  • tell your doctor if you have or have ever had kidney disease, liver disease, seizures, or a blood disorder.
  • tell your doctor if you are pregnant, plan to become pregnant, or are breastfeeding. If you become pregnant while taking metaxalone, call your doctor immediately.
  • talk to your doctor about the risks and benefits of taking metaxalone if you are 65 years of age or older. Older adults should not usually take metaxalone because it is not as safe or effective as other medications that can be used to treat the same condition.
  • you should know that this drug may make you drowsy. Do not drive a car or operate machinery until you know how metaxalone affects you.
  • remember that alcohol can add to the drowsiness caused by this drug.

Take the missed dose as soon as you remember it. However, if it is almost time for your next dose, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.

Metaxalone may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

  • drowsiness
  • dizziness
  • headache
  • nervousness

If you experience any of the following symptoms, call your doctor immediately:

  • agitation, hallucinations, coma
  • fast heart rate, high body temperature
  • muscle twitching, loss of muscle control
  • nausea, vomiting, diarrhea
  • severe skin rash
  • difficulty breathing
  • yellowing of the skin or eyes
  • unusual bruising or bleeding
  • unusual tiredness or weakness
  • seizures

If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration’s (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).

Keep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature, away from excess heat and moisture (not in the bathroom).

It is important to keep all medication out of sight and reach of children as many containers (such as weekly pill minders and those for eye drops, creams, patches, and inhalers) are not child-resistant and young children can open them easily. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location – one that is up and away and out of their sight and reach. http://www.upandaway.org

Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them. However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. See the FDA’s Safe Disposal of Medicines website (http://goo. gl/c4Rm4p) for more information if you do not have access to a take-back program.

In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can’t be awakened, immediately call emergency services at 911.

  • Skelaxin®

Last Revised – 07/15/2022

Browse Drugs and Medicines

Skelaxin Tablet English – Product

Skelaxin Tablet English – Product – TabletWise.com

About Us

  • About Us
  • Privacy Policy
  • Terms of use

  • Overview
  • Benefits
  • Side effects
  • Precautions
  • Interactions
  • Contraindications


Skelaxin Tablet is used for Relieving muscle spasms, Used in conjunction with rest and physical therapy, Muscle relaxation and other conditions.

Skelaxin Tablet contains Metaxalone as an active ingredient. Available in tablet form.

Detailed information regarding the use, composition, dosage, side effects of Skelaxin Tablet, as well as user reviews are provided below:


Skelaxin Tablet is used for the treatment, control, prevention, & improvement of the following diseases, conditions and symptoms:

  • Relieve muscle spasms
  • Used in conjunction with rest and physical therapy
  • Muscle relaxation

Learn more : Benefits

Side effects

The following is a list of possible side-effects that may occur from all constituents of Skelaxin Tablet. This list is not final. These side effects have been recorded previously, but are not always recorded when using the drug. Some of these side effects may be extremely rare, but have incredibly severe consequences. If you notice any side effects, contact your doctor immediately. Especially in the case of observing side effects for a long time.

  • Nausea
  • Jaundice
  • Acute and severe allergic reactions
  • Vomiting
  • Drowsiness
  • Hemolytic anemia
  • Indigestion
  • Allergic rejection
  • Dizziness
  • Nervousness or irritability
  • Less white blood cells with or without itching
  • Headache
  • Blurred vision
  • Dry mouth
  • Constipation

If you experience side effects not listed above, contact your healthcare provider for advice. In addition, you can report side effects to your local Food and Drug Administration.


Before starting this drug, tell your doctor about any medications you are taking, dietary supplements (such as vitamins, natural supplements, etc.), allergies, existing medical conditions, and current health conditions (such as pregnancy, upcoming surgery, and etc. ). The side effects of the drug may be more pronounced depending on the state of your body. Take this medicine as directed by your doctor, or follow the directions for use that come with your medicine. The dosage of the drug depends on your condition. Tell your doctor if there is no change or if your condition worsens. Important points to discuss with your healthcare provider are listed below.

  • Do not take with food
  • Pre-existing liver damage

If you use other drugs or over the counter products at the same time, the effects of Skelaxin Tablet may change. Tell your healthcare provider about all medications, vitamins, and supplements you use. Your doctor will be able to make the right plan for taking the drug, which will avoid negative interactions. Skelaxin Tablet may interact with the following drugs and products:

  • Acetaminophen
  • Aspirin
  • Buprenorphine
  • Caffeine
  • Juxtapid
  • Kynamro
  • Leflunomide 90 008
  • Lomitapide
  • Mipomersen
  • Naloxone

Hypersensitivity to Skelaxin Tablet is a contraindication. In addition, Skelaxin Tablet should not be used if you have the following conditions:

  • Drug-induced hemolytic anemia or other
  • Impaired renal and hepatic function
  • hypersensitivity

Composition and active ingredients

Skelaxin Tablet contains the following active ingredients (salts)

90 005

  • Metaxalone
  • Please note attention to the fact that this drug is available with different strengths of intensity for each of the active ingredients listed above.

    Packing options and strengths

    Skelaxin Tablet is available in the following pack sizes and strengths

    Skelaxin Tablet packs are available: 400MG, 800MG


      900 06

      Can Skelaxin tablets / Skelaxin Tablet is used to relieve muscle spasms and is used along with rest and physical therapy?

      Yes, relieve muscle spasms and used along with rest and physical therapy are among the most common reported uses for Skelaxin Tablet. Please do not use Skelaxin Tablet to relieve muscle spasms and is used along with other and physical therapy without consulting first with your doctor. Click here and view survey results to find out what other patients report as common uses of Skelaxin Tablet.

    • Is it safe to drive or operate heavy machinery while using this product?

      If you experience drowsiness, dizziness, hypotension or a headache as side-effects when using Skelaxin Tablet medicine then it may not be safe to drive a vehicle or operate heavy machinery. You should stop driving if taking this medicine makes you drowsy, dizzy, or hypotensive. Doctors recommend that you stop drinking alcohol with such drugs, because. alcohol greatly increases the side effects and drowsiness. Please check for these effects on your body when using Skelaxin Tablet. Be sure to consult your doctor for advice based on the characteristics of your body and general health.

    • Is this drug (product) addictive or addictive?

      Most drugs are not habit-forming or addictive. In most cases, the state classifies drugs that can be addictive as controlled dispensing drugs. For example, schedule H or X in India and schedule II-V in the USA. Please check the information on the drug packaging to make sure that this drug is not in the controlled category. Also, do not self-medicate or accustom your body to medications without consulting your doctor.

    • Can I stop using this product immediately or do I need to slowly stop using it?

      Some medications need to be stopped gradually due to a rebound effect. Be sure to check with your healthcare provider for advice based on your body, general health, and other medications you may be taking.

    Cite this page

    Page URL

    HTML Link

    Skelaxin Tablet

    APA Style Citation – Product – TabletWise.com. (n.d.). Retrieved March 17, 2023, from https://www.tabletwise.com/us-ru/skelaxin-tablet
    MLA Style Citation
    • “Skelaxin Tablet in English – Product – TabletWise. com” Tabletwise .com . N.p., n.d. Web. 17 Mar. 2023.
    Chicago Style Citation
    • Skelaxin Tablet in English – Product – TabletWise.com Tabletwise. Accessed March 17, 2023. https://www.tabletwise.com/us-ru/skelaxin-tablet.

    More information about Skelaxin Tablet

    • Uses of
    • Reviews
    • What are the uses of Skelaxin Tablet?
    • What are the side effects of Skelaxin Tablet?
    • What other medicines does Skelaxin Tablet interact with?
    • When should you not use Skelaxin Tablet?
    • What precautions should you take while using Skelaxin Tablet?

    Last updated date

    This page was updated on 9/28/2020.

    This page provides information for Skelaxin Tablet Product in English .

    Share with friends, get 20% off

    Invite your friends to TabletWise learning marketplace. For each purchase they make, you get 20% off (upto $10) on your next purchase.

    Skelaxin (Metaxalone): Uses, Dosage, Side Effects, Interactions, Prevention

  • Side effects and drug interactions
  • Warnings and Precautions
  • Overdose and Contraindications
  • Clinical Pharmacology
  • Medication Guide
  • Product Description

    What is skelaxin and how is it used?

    Skelaxin is a prescription medicine used to treat the symptoms of musculoskeletal pain. Skelaxin can be used alone or with other medicines.

    Skelaxin belongs to a class of drugs called skeletal muscle relaxants.

    It is not known whether Skelaxin is safe and effective in children under 12 years of age.

    What are the possible side effects of Skelaxin?

    Skelaxin can cause serious side effects, including:

    • weak or shallow breathing,
    • lightheadedness,
    • pale or yellow skin,
    • dark colored urine,
    • confusion,
    • weak point
    • upper stomach pain,
    • loss of appetite and
    • yellowing of the skin or eyes (jaundice)

    Get medical help right away if you have any of the above symptoms.

    The most common side effects of Skelaxin include:

    • dizziness,
    • drowsiness,
    • nausea,
    • vomiting,
    • upset stomach,
    • 9000 6 headache and

    • feeling of nervousness or irritability

    Tell your doctor if you have any side effects that bother you or that don’t go away.

    These are not all possible side effects of Skelaxin. For more information, contact your doctor or pharmacist.

    Ask your doctor about side effects. You can report side effects to the FDA at 1-800-FDA-1088.


    SKELAXIN (Metaxalone) is available as oval pink tablets with a score of 800 mg.

    Chemically, metaxalone is 5-[(3,5-dimethylphenoxy)methyl]-2-oxazolidinone. Empirical formula: C 12 H fifteen HE 3 corresponding to a molecular weight of 221.25. Structural formula:

    Metaxalone is an odorless white or almost white crystalline powder, easily soluble in chloroform, soluble in methanol and 96% ethanol, but practically insoluble in ether or water.

    Each tablet contains 800 mg of metaxalone and the following inactive ingredients: alginic acid, ammonium calcium alginate, B-Rose liquid, corn starch and magnesium stearate.



    SKELAXIN (metaxalone) is indicated as an adjunct to rest, physical therapy and other measures to relieve discomfort associated with acute, painful musculoskeletal problems. The mechanism of action of this drug has not been precisely established, but may be related to its sedative properties. Metaxalone does not directly relax tense human skeletal muscles.


    The recommended dose for adults and children over 12 years of age is one 800 mg tablet three to four times daily.


    SKELAXIN (Metaxalone) Available as an 800 mg scored oval pink tablet, debossed with 8667 on the grooved side and an ‘S’ on the other side. Available in vials of 100 ( NDC 60793-136-01) and in vials of 500 ( NDC 60793-136-05).

    Store at controlled room temperature between 15°C and 30°C (59°F and 86 °F).

    SKELAXIN is a registered trademark of King Pharmaceuticals Research and Development, Inc.

    Distributed by: Pfizer Inc., New York, NY 10017. Revised: November 2015

    Side effects and drug interactions


    The most common reactions to metaxalone include:

    9 0003 CNS: drowsiness, dizziness headache and nervousness or “irritability”;

    Digestive: nausea, vomiting, gastrointestinal upset.

    Other adverse reactions:

    Immune system: hypersensitivity reaction, rash with or without itching;

    Hematological: leukopenia; hemolytic anemia;

    Hepatobiliary: jaundice.

    side effects from Kenalog 40 injection

    Anaphylactoid reactions have been reported with metaxalone, although rare.


    No information provided.

    Warnings and Precautions


    Potentially life-threatening serotonin syndrome (SS) has been reported with the use of metaxalone. These reports have usually occurred when metaxalone was used concomitantly with serotonergic drugs (such as tramadol or selective serotonin reuptake inhibitors (SSRIs)) or when metaxalone was used at higher than recommended doses (see DRUG INTERACTIONS and OVERDOSE ). Signs of SS may include clonus, agitation, sweating, tremors, hyperreflexia, hypertonicity, and fever.

    SKELAXIN may potentiate the effects of alcohol and other CNS depressants.


    Metaxalone should be used with great caution in patients with pre-existing liver disease. In such patients, serial liver function tests should be performed.

    Benedict’s false positive tests have been noted due to an unknown reducing agent. A specific glucose test will differentiate the results.

    Dietary intake of SKELaxin may increase overall CNS depression; Elderly patients may be particularly sensitive to such CNS effects. (See CLINICAL PHARMACOLOGY : Pharmacokinetics and PATIENT INFORMATION ).

    Carcinogenesis, mutagenesis, impaired fertility

    The carcinogenic potential of metaxalone has not been determined.


    Reproduction studies in rats showed no evidence of impaired fertility or harm to the fetus due to metaxalone. Post-marketing experience has not shown evidence of fetal injury, but such experience cannot rule out the possibility of infrequent or minor injury to the human fetus. The safe use of metaxalone has not been established with regard to possible adverse effects on fetal development. Therefore, metaxalone tablets should not be used by women who are pregnant or planning pregnancy, especially in early pregnancy, unless, in the opinion of the physician, the potential benefits outweigh the possible risks.

    Nursing mothers

    It is not known whether this drug is secreted in breast milk. As a general rule, breastfeeding should not be done while the patient is taking medication, as many medications are excreted in breast milk.

    Pediatric use

    Safety and efficacy in children under 12 years of age have not been established.

    Overdose and contraindications


    Deaths due to intentional or accidental overdose have occurred with the use of metaxalone, especially in combination with antidepressants, and cases of this class of drugs in combination with alcohol have been reported.

    Serotonin syndrome has been reported when higher than recommended doses of metaxalone have been reported (see WARNINGS ).

    When determining the LD 50 in rats and mice with increasing dosage, progressive sedation, hypnosis and, finally, respiratory failure were noted. In dogs no LD 50 could be determined as higher doses caused emesis after 15-30 minutes.


    Gastric lavage and supportive care. It is recommended to consult with the regional poison control center.


    Known hypersensitivity to any component of this product.

    Known tendency to drug-induced, hemolytic or other anemia.

    Significant impairment of kidney or liver function.

    Clinical pharmacology


    Mechanism of action

    The mechanism of action of metaxalone in humans has not been established, but it may be associated with general depression of the central nervous system.

    Metaxalone has no direct action on the contractile mechanism of the striated muscle, motor end plate or nerve fiber.


    The pharmacokinetics of metaxalone was evaluated in healthy adult volunteers after administration of a single dose of SKELaxin on an empty stomach and after meals at doses ranging from 400 to 800 mg.


    Peak plasma concentrations of metaxalone occur approximately 3 hours after oral administration of 400 mg on an empty stomach. Thereafter, metaxalone concentrations decrease logarithmically with a terminal half-life of 9.0 ± 4. 8 hours. Doubling the dose of SKELaxin from 400 mg to 800 mg results in an approximately proportional increase in metaxalone exposure, as evidenced by peak plasma concentrations (Cmax) and area under the curve (AUC). Dose proportionality at doses above 800 mg has not been studied. The absolute bioavailability of metaxalone is unknown.

    Pharmacokinetic parameters of a single dose of metaxalone in two groups of healthy volunteers are presented in Table 1.

    Table 1: Mean (% CV) pharmacokinetic parameters of metaxalone

    Dose (mg) Cmax (ng/ml) Tmax (h) AUC & infin; (ng & bull; h / ml) t & frac12; CL / F (51) 9.0 (53) 68 (50)
    800 two0366

    8.0 (58) 66 (51)
    one Subjects received 1 tablet of 400 mg on an empty stomach (N = 42).
    two Subjects received 2 x 400 mg tablets on an empty stomach (N = 59).
    Nutritional effects

    A randomized, two-way crossover study was conducted in 42 healthy volunteers (31 men, 11 women) who were administered one tablet of SKELAXIN 400 mg on an empty stomach and after a standard high-fat breakfast. The age of the subjects ranged from 18 to 48 years (mean age = 23.5 ± 5.7 years). Compared to fasting conditions, the presence of a high-fat meal during drug administration increased Cmax by 177.5% and increased AUC (AUC0-t, AUC.infin.) by 123.5% and 115.4%, respectively. The time to reach maximum concentration (Tmax) was also delayed (4.3 hours compared to 3.3 hours) and the terminal half-life was reduced (2.4 hours compared to 90 hours) under eating conditions compared with fasting.

    In a second food impact study with a similar design, two 400 mg (800 mg) SKELAXIN tablets were administered to healthy volunteers (N = 59, 37 males, 22 females) aged 18 to 50 years (mean age = 25. 6 ± 8.7 years). Compared to fasting conditions, the presence of a high-fat meal during drug administration increased Cmax by 193.6% and increased AUC (AUC0-t, AUC & infin;) by 146.4% and 142.2%, respectively. The time to reach maximum concentration (Tmax) was also delayed (4.9hours compared to 3.0 hours), and the terminal elimination half-life decreased (4.2 hours compared to 8.0 hours) under conditions of food intake compared with conditions on an empty stomach. Similar nutritional effects results were observed in the aforementioned study when one SKELAXIN 800 mg tablet was administered instead of two SKELAXIN 400 mg tablets. An increase in metaxalone exposure, coinciding with a decrease in half-life, may be due to more complete absorption of metaxalone in the presence of a high-fat meal (Fig. 1).

    Figure 1: Mean (SD) concentrations of metaxalone after a dose of 800 mg under fasting and feeding conditions

    Distribution, metabolism and excretion

    Although plasma protein binding and absolute bioavailability of metaxalone are unknown, it appears the volume of distribution (V/F ~ 800 L) and lipophilicity (log P = 2. 42) of metaxalone suggest that the drug is widely distributed in tissues. Metaxalone is metabolized in the liver and excreted in the urine as unidentified metabolites. Liver cytochrome P450 enzymes play a role in the metabolism of metaxalone. In particular, CYP1A2, CYP2D6, CYP2E1 and CYP3A4 and, to a lesser extent, CYP2C8, CYP2C9and CYP2C19 appear to metabolize metaxalone.

    Metaxalone slightly inhibits major CYP enzymes such as CYP1A2, CYP2A6, CYP2B6, CYP2C8, CYP2C9, CYP2C19, CYP2D6, CYP2E1 and CYP3A4. Metaxalone slightly induces major CYP enzymes such as CYP1A2, CYP2B6 and CYP3A4. in vitro .

    Pharmacokinetics in special populations

    The effect of age on the pharmacokinetics of metaxalone was determined after a single dose of two 400 mg (800 mg) tablets on an empty stomach and after a meal. The results were analyzed separately and also in combination with the results of three other studies. Using the pooled data, the results show that the pharmacokinetics of metaxalone are significantly more dependent on age under fasted conditions than under food conditions, with fasting bioavailability increasing with age.

    The fasting and postprandial bioavailability of metaxalone in three groups of healthy volunteers of different ages is shown in Table 2. feeding

    9 0635 39.3 ± 10.8

    9055 0 2915 (55)

    9 0550 23797 (45)

    Age (years) Young volunteers Older volunteers
    25.6 ± 8.7 71.5 ± 5.0
    N 59 21 2. 3
    Food Hungry fed Hungry fed Hungry fed
    Cmax (ng/ml) 1816 (43) 3510 (41) 2719 (46) 3168 (43) 3680 (59)
    Tmax (h) 3.0 (39) 4.9 (48) 3. 0 (40) 8.7 (91) 2.6 (30) 6.5 (67) 90 366
    AUC0-t (ng and steer / ml) 14531 (47) 20683 (41) 19836 (40) 20482 (37) 24340 (48)
    AUC & infin; (ng & bull; h / ml) 15045 (46) 20833 (41) 20490 (39) 20815 (37) 24194 (44) 24704 (47)
    Gender women) were administered two SKELAXIN 400 mg tablets ( 800 mg) on ​​an empty stomach. Bioavailability of metaxalone was significantly higher in women compared to men as evidenced by Cmax (2115 ng/mL vs 1335 ng/mL) and AUC∞ (17884 ng-middot; h/ml compared to 10328 ng-middot; h/ml). The mean elimination half-life was 11.

    1 hours in women and 7.6 hours in men. The apparent volume of distribution of metaxalone was approximately 22% higher in men than in women, but differed slightly when adjusted for body weight. Similar results were also obtained when the previously described combined dataset was used in the analysis.

    Hepatic / renal failure

    The effect of liver and kidney disease on the pharmacokinetics of metaxalone has not been determined. In the absence of such information, SKELaxin should be used with caution in patients with hepatic and/or renal impairment.

    Medication Guide


    SKELAXIN may impair the mental and/or physical abilities required to perform hazardous tasks such as operating machinery or driving a car, especially when used with alcohol or other CNS depressants.


    The sedative effect of SCELaxin and other CNS depressants (eg, alcohol, benzodiazepines, opioids, tricyclic antidepressants) can be complex.